Clinical Trial Update: Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics trial evaluating apixaban in patients with short bowel syndrome requiring long-term parenteral nutrition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anticoagulation
• Short Bowel Syndrome

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Short Bowel Syndrome, Anticoagulation | Phase 4 | Status: UNKNOWN